Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 3Withdrawn 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 51Neoplasms 34Colorectal Neoplasms 23Lung Neoplasms 17Prostatic Neoplasms 16Melanoma 15Neoplastic Cells, Circulating 13Pancreatic Neoplasms 11Multiple Myeloma 11Uterine Cervical Neoplasms 10Ovarian Neoplasms 10Carcinoma, Non-Small-Cell Lung 8Papillomavirus Infections 7Neoplasm Metastasis 7Leukemia, Myeloid, Acute 7Colonic Neoplasms 7Lymphoma, Follicular 6Lymphoma 6Hematologic Neoplasms 6Uveal Melanoma 5Sarcoma 5Head and Neck Neoplasms 5Glioma 5Uterine Cervical Dysplasia 4Urinary Bladder Neoplasms 4Rectal Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Glioblastoma 4Disease 4COVID-19 4

Interventions

Carboplatin 41Paclitaxel 40pembrolizumab 38Cyclophosphamide 23Gemcitabine 22130-nm albumin-bound paclitaxel 21Doxorubicin 18Cisplatin 18Albumin-Bound Paclitaxel 18atezolizumab 16Taxes 15Capecitabine 13veliparib 10Nivolumab 9Docetaxel 9Bevacizumab 9olaparib 8liposomal doxorubicin 7Everolimus 7spartalizumab 6durvalumab 6Epirubicin 6trametinib 5pegfilgrastim 5eribulin 5Irinotecan 5Filgrastim 5iniparib 4binimetinib 4apatinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Triple Negative Breast Neoplasms × Blood Specimen Collection × Clear all
NCT00930930 2015-05-07

Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer

Vanderbilt-Ingram Cancer Center

Phase 2 Completed
145 enrolled 10 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡